This week I attended the conference of HBI’s sister company, IPEM, in Paris. The event is a meeting place for private equity GPs and LPs, and featured many interesting panel discussions on the current state of the industry.
Watching Paris host first the Olympic Games and now the Paralympic Games has been a pleasure that I’m sure many of you will have enjoyed this summer. The Games, which have been organised to be the most sustainable ever, have proven the ultimate showcase for a city which will always be synonymous with enlightenment and of course romance.
Private equity (PE) is increasingly investing in healthcare due to high returns and societal impact. HBI recently reported on the rebound in European healthcare investments, with ~€9 billion across 154 deals by August 2024, signalling renewed sector momentum after 2023’s decline.
Here at HBI, we’re always exploring innovative ways to deliver healthcare content to our readers. I recently read an article on LinkedIn titled ‘The Double-Edged Sword of Hyperspecialisation in Medicine: Challenges of Choosing the Right Doctor’. This article prompted me to reflect on how hyperspecialisation impacts patient care and its implications for healthcare investors, especially given […]
For many of us, August is the time of year to take a breather, whether that is jetting off for a break at the beach, or taking some time to relax at home. Alas, not so for us in the editorial and data teams here at HBI!
A new study published in The Journal of the American Medical Association examines what happens to the total value of assets held by hospitals after they are acquired by PE firms, finding that it typically drops. Does this suggest PE firms are guilty of ‘asset stripping’ hospitals to enrich shareholders at the expense of hospitals’ long term interest?
Last month we reported that healthcare M&A investment may be through the bottom of the cycle, after two years of downturn.
But it’s not just M&A of healthcare services providers that has been negatively impacted by the increase in interest rates over the past two years. Venture capital investment into health tech start-ups and scale-ups has also been affected, but now may be about to rebound.
While not a new trend, recent innovations spark debate on the efficiency and effectiveness of healthcare services in supermarkets.
Healthcare globally faces challenges, with the UK grappling with workforce shortages and increasing NHS wait lists.
This week the UK’s Financial Conduct Authority (FCA), which regulates the UK’s financial markets, set out changes to the rules for publicly listing on the stock market in the UK.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.